Scientific Clinical Laboratories

Scientific Clinical Laboratories provides high-quality medical diagnostic services, specializing in customized laboratory tests across various disciplines to support healthcare providers and individual clients in the Middle East. Founded in 1990 and headquartered in Dubai, United Arab Emirates, Scientific Clinical Laboratories (SCL) offers comprehensive medical diagnostic services. The company operates independently without known subsidiaries or pivots in business strategy. The CEO, Mohammed Daoud, leads the company toward achieving its operational goals.

SCL has engaged in 2 financial deals since its inception. Scientific Clinical Laboratories (SCL) specializes in high-quality medical diagnostic services, offering a range of customized laboratory tests designed to meet the diverse needs of healthcare providers and individual clients. The laboratory's core offerings span various disciplines, including clinical pathology, microbiology, hematology, histopathology, immunology, endocrinology, and genetics, among others. SCL operates in compliance with ISO 15189 standards, ensuring the reliability and accuracy of its diagnostic services, which help identify infectious diseases, monitor blood-related conditions, and evaluate endocrine functions.

The company serves a broad client base, including healthcare facilities, medical professionals, and individual patients throughout the Middle East, ensuring access to advanced diagnostic testing to support health and well-being. The revenue model of Scientific Clinical Laboratories is primarily based on direct transactions with healthcare providers, individual clients, and partnerships with other medical entities. Clients can request various lab tests, and the laboratory provides comprehensive packages tailored to meet specific healthcare needs. Revenue is generated through fee-for-service arrangements, where clients pay for individual tests or bundled services, which could include specialized offerings like the Panorama™ non-invasive prenatal test.

The business structure supports both B2B relationships with healthcare facilities and direct-to-consumer interactions, facilitating a streamlined approach for clients seeking diagnostic insights. The laboratory maintains competitive pricing strategies to ensure accessibility while delivering high-quality testing services. Scientific Clinical Laboratories plans to expand its service offerings by developing new diagnostic tests tailored to emerging healthcare needs. The company aims to penetrate additional markets in the Middle East by 2025, particularly targeting Saudi Arabia and Qatar.

Recent funding will support these initiatives, allowing for the enhancement of laboratory facilities and marketing efforts to raise awareness of its services. Additionally, Unilabs AB, previously a stakeholder, exited its investment in SCL, further emphasizing the company's potential for growth.